Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07216391
What this trial is testing

Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 60
Not applicableUnknownNCT03337568
What this trial is testing

Allogeneic HCT Using Uniform Conditioning Regimen Regardless of Donors (MS, MU, or HF) for AML in Remission

Who this might be right for
Acute Myeloid Leukemia
Asan Medical Center 110
Post-approval studies (Phase 4)Study completedNCT05996393
What this trial is testing

CsA+ATG+AVA vs. CsA+AVA for the Treatment of Newly-diagnosed SAA in the Elderly

Who this might be right for
Aplastic Anemia
Peking Union Medical College Hospital 86
Testing effectiveness (Phase 2)Study completedNCT02215200
What this trial is testing

ATG-GCSF in New Onset Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 89
Testing effectiveness (Phase 2)Study completedNCT00228852
What this trial is testing

IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency

Who this might be right for
T-Cell Immune Deficiency DiseasesSevere Combined Immunodeficiency
Emory University
Testing effectiveness (Phase 2)Study completedNCT00896493
What this trial is testing

Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma

Who this might be right for
MycosesSezary SyndromeLymphoma, T-Cell, Cutaneous+3 more
Stanford University 38
Large-scale testing (Phase 3)Active Not RecruitingNCT05153226
What this trial is testing

GvHD Prophylaxis in Unrelated Donor HCT: Randomized Trial Comparing PTCY Versus ATG

Who this might be right for
Graft Vs Host DiseasePeripheral Blood Stem Cell TransplantationAML+3 more
DKMS gemeinnützige GmbH 640
Post-approval studies (Phase 4)UnknownNCT03828682
What this trial is testing

Veloxis de Novo Kidney Transplant ECSWD

Who this might be right for
Kidney TransplantationImmunosuppression
Simon Tremblay, PharmD, PhD 60
Testing effectiveness (Phase 2)Study completedNCT00017550
What this trial is testing

Antithymocyte Globulin Compared With Supportive Care in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndromes
Genzyme, a Sanofi Company
Post-approval studies (Phase 4)UnknownNCT03088280
What this trial is testing

Efficacy and Safety of Rabbit Antithymocyte Globulin 3mg/kg in Kidney Transplant Patients Under Steroid-free and CNI Minimization Maintenance Immunosuppressive Regimen

Who this might be right for
Thymoglobulin Dose
Hospital Geral de Fortaleza 200
Testing effectiveness (Phase 2)UnknownNCT00750971
What this trial is testing

Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST)

Who this might be right for
Systemic Lupus Erythematosus
Charite University, Berlin, Germany 30
Post-approval studies (Phase 4)Ended earlyNCT00596947
What this trial is testing

Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant

Who this might be right for
Transplants and Implants
University of Pennsylvania 18
Not applicableUnknownNCT02843841
What this trial is testing

Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Centre Hospitalier Universitaire de Besancon 63
Large-scale testing (Phase 3)Study completedNCT00035880
What this trial is testing

Study Comparing ABX-CBL (Monoclonal Antibody) Versus Atgam in Patients With Steroid Resistant Acute Graft Versus Host Disease

Who this might be right for
Graft Vs Host Disease
Abgenix 95
Testing effectiveness (Phase 2)UnknownNCT00466843
What this trial is testing

Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
Office of Rare Diseases (ORD) 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634562
What this trial is testing

TLI- and ATG-Enabled Minimization Protocol in Liver Transplantation

Who this might be right for
Liver Failure
Stanford University 12
Testing effectiveness (Phase 2)Study completedNCT00185796
What this trial is testing

TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

Who this might be right for
Myeloproliferative DisordersBlood CancerMyelodysplastic Syndromes
Stanford University 77
Early research (Phase 1)Study completedNCT01362452
What this trial is testing

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00005853
What this trial is testing

Biological Therapy in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Study completedNCT04302805
What this trial is testing

RATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT)

Who this might be right for
Kidney Transplantation
Institute for Clinical and Experimental Medicine 17
Next Page